Osterix Induces Osteogenic Gene Expression but not Differentiation in Primary Human Fetal Mesenchymal Stem Cells

2007 ◽  
Vol 13 (7) ◽  
pp. 1513-1523 ◽  
Author(s):  
Hitoshi Kurata ◽  
Pascale V. Guillot ◽  
Jerry Chan ◽  
Nicholas M. Fisk
Keyword(s):  
Gene Expression ◽  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Osteogenic Gene Expression ◽  
Osteogenic Gene

scholarly journals MicroRNA treatment modulates osteogenic differentiation potential of mesenchymal stem cells derived from human chorion and placenta

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Kulisara Marupanthorn ◽  
Chairat Tantrawatpan ◽  
Pakpoom Kheolamai ◽  
Duangrat Tantikanlayaporn ◽  
Sirikul Manochantr
Keyword(s):  
Gene Expression ◽  
Stem Cells ◽  
Bone Marrow ◽  
Mesenchymal Stem Cells ◽  
Transcription Factor ◽  
Osteogenic Differentiation ◽  
Differentiation Potential ◽  
Osteogenic Gene Expression ◽  
Osteogenic Gene

AbstractMesenchymal stem cells (MSCs) are important in regenerative medicine because of their potential for multi-differentiation. Bone marrow, chorion and placenta have all been suggested as potential sources for clinical application. However, the osteogenic differentiation potential of MSCs derived from chorion or placenta is not very efficient. Bone morphogenetic protein-2 (BMP-2) plays an important role in bone development. Its effect on osteogenic augmentation has been addressed in several studies. Recent studies have also shown a relationship between miRNAs and osteogenesis. We hypothesized that miRNAs targeted to Runt-related transcription factor 2 (Runx-2), a major transcription factor of osteogenesis, are responsible for regulating the differentiation of MSCs into osteoblasts. This study examines the effect of BMP-2 on the osteogenic differentiation of MSCs isolated from chorion and placenta in comparison to bone marrow-derived MSCs and investigates the role of miRNAs in the osteogenic differentiation of MSCs from these sources. MSCs were isolated from human bone marrow, chorion and placenta. The osteogenic differentiation potential after BMP-2 treatment was examined using ALP staining, ALP activity assay, and osteogenic gene expression. Candidate miRNAs were selected and their expression levels during osteoblastic differentiation were examined using real-time RT-PCR. The role of these miRNAs in osteogenesis was investigated by transfection with specific miRNA inhibitors. The level of osteogenic differentiation was monitored after anti-miRNA treatment. MSCs isolated from chorion and placenta exhibited self-renewal capacity and multi-lineage differentiation potential similar to MSCs isolated from bone marrow. BMP-2 treated MSCs showed higher ALP levels and osteogenic gene expression compared to untreated MSCs. All investigated miRNAs (miR-31, miR-106a and miR148) were consistently downregulated during the process of osteogenic differentiation. After treatment with miRNA inhibitors, ALP activity and osteogenic gene expression increased over the time of osteogenic differentiation. BMP-2 has a positive effect on osteogenic differentiation of chorion- and placenta-derived MSCs. The inhibition of specific miRNAs enhanced the osteogenic differentiation capacity of various MSCs in culture and this strategy might be used to promote bone regeneration. However, further in vivo experiments are required to assess the validity of this approach.

scholarly journals Monocyte Exosomes Stimulate the Osteogenic Gene Expression of Mesenchymal Stem Cells

PLoS ONE ◽  
2013 ◽  
Vol 8 (9) ◽  
pp. e75227 ◽  
Author(s):  
Karin Ekström ◽  
Omar Omar ◽  
Cecilia Granéli ◽  
Xiaoqin Wang ◽  
Forugh Vazirisani ◽  
...  
Keyword(s):  
Gene Expression ◽  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Osteogenic Gene Expression ◽  
Osteogenic Gene

Stimulators of osteogenic gene expression in human mesenchymal stem cells into osteoblasts in vitro

Bone ◽  
2012 ◽  
Vol 50 ◽  
pp. S164
Author(s):  
T. Kim⁎ ◽  
S. Lee ◽  
H.-Y. Chung ◽  
D.-W. Byun ◽  
M.-I. Kang ◽  
...  
Keyword(s):  
Gene Expression ◽  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Human Mesenchymal Stem Cells ◽  
Osteogenic Gene Expression ◽  
Osteogenic Gene

scholarly journals Bisphosphonates induce the osteogenic gene expression in co‐cultured human endothelial and mesenchymal stem cells

2013 ◽  
Vol 18 (1) ◽  
pp. 27-37 ◽  
Author(s):  
Viviana Ribeiro ◽  
Mónica Garcia ◽  
Raquel Oliveira ◽  
Pedro S. Gomes ◽  
Bruno Colaço ◽  
...  
Keyword(s):  
Gene Expression ◽  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Osteogenic Gene Expression ◽  
Osteogenic Gene

scholarly journals 5-Azacytidine facilitates osteogenic gene expression and differentiation of mesenchymal stem cells by alteration in DNA methylation

2009 ◽  
Vol 60 (1-3) ◽  
pp. 11-22 ◽  
Author(s):  
Guo-Shun Zhou ◽  
Xiao-Lei Zhang ◽  
Jun-Ping Wu ◽  
Rui-Peng Zhang ◽  
Li-Xin Xiang ◽  
...  
Keyword(s):  
Gene Expression ◽  
Dna Methylation ◽  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Osteogenic Gene Expression ◽  
Osteogenic Gene

scholarly journals Dual Ion Releasing Nanoparticles for Modulating Osteogenic Cellular Microenvironment of Human Mesenchymal Stem Cells

Materials ◽  
2021 ◽  
Vol 14 (2) ◽  
pp. 412
Author(s):  
Yu-Jin Kim ◽  
Jaeyoung Lee ◽  
Gwang-Bum Im ◽  
Jihun Song ◽  
Jiwoo Song ◽  
...  
Keyword(s):  
Gene Expression ◽  
Stem Cells ◽  
Mesenchymal Stem Cells ◽  
Osteogenic Differentiation ◽  
Metal Ion ◽  
Reactive Oxygen Species Generation ◽  
Human Mesenchymal Stem Cells ◽  
Osteogenic Gene Expression ◽  
Factor Secretion ◽  
Osteogenic Gene

In this study we developed a dual therapeutic metal ion-releasing nanoparticle for advanced osteogenic differentiation of stem cells. In order to enhance the osteogenic differentiation of human mesenchymal stem cells (hMSCs) and induce angiogenesis, zinc (Zn) and iron (Fe) were synthesized together into a nanoparticle with a pH-sensitive degradation property. Zn and Fe were loaded within the nanoparticles to promote early osteogenic gene expression and to induce angiogenic paracrine factor secretion for hMSCs. In vitro studies revealed that treating an optimized concentration of our zinc-based iron oxide nanoparticles to hMSCs delivered Zn and Fe ion in a controlled release manner and supported osteogenic gene expression (RUNX2 and alkaline phosphatase) with improved vascular endothelial growth factor secretion. Simultaneous intracellular release of Zn and Fe ions through the endocytosis of the nanoparticles further modulated the mild reactive oxygen species generation level in hMSCs without cytotoxicity and thus improved the osteogenic capacity of the stem cells. Current results suggest that our dual ion releasing nanoparticles might provide a promising platform for future biomedical applications.

Sign in / Sign up

Export Citation Format

Share Document